Y Pan, T Xiao, Y Wang, Z Pan, S Du, F Xue - Molecules, 2024 - mdpi.com
Axitinib (AXTN) is an oral tyrosine kinase inhibitor for the treatment of early to advanced
renal cell carcinoma. In this work, solvates of AXTN were prepared in five solvents and …